Exercise in the hospital: a new way to help heart failure patients help themselves?
NCT ID NCT06528561
First seen Aug 21, 2026 · Last updated Aug 21, 2026
Summary
This trial tests whether a structured exercise program—combining aerobic and strength training—can improve self-care ability in people hospitalized for heart failure. Participants will be randomly assigned to either this combined program or a standard aerobic-only exercise program during their hospital stay. Researchers will measure functional capacity, muscle strength, and self-care skills at admission, discharge, and one month later. The goal is to see if adding strength training helps patients better manage their condition after leaving the hospital.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- A structured physical exercise program combining aerobic and muscle-strengthening activities, delivered during a hospital stay for heart failure.
- What this could lead to
- If effective, this program could become a standard part of hospital care for heart failure, helping patients recover strength and manage their condition better after discharge.
- What could go wrong
- The trial is small (63 participants) and early, so results may not apply to all heart failure patients. Exercise during hospitalization carries risks like fatigue or strain, though the program is designed to be progressive and safe.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
63 people
The number who actually took part.
- Started
-
Aug 2024
- Finished
-
Apr 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants: Clinical diagnosis of decompensated HF, regardless of etiology or ventricular function; * Participants: Be over 18 years old; * Participants: Be able to provide informed consent. Exclusion Criteria (participants): * Osteoarticular pathology that causes physical limitations that prevent the performance of physical exercise; * Existence of intravenous inotropic medication; * Uncontrolled auricular or ventricular arrhythmias; * Chest pain in the last 8 hours; * Heart rate greater than 120; * Dyspnea at rest; * Uncontrolled blood pressure - Systolic blood pressure greater than 180mmHg or diastolic blood pressure greater than 110mmHg; * 2nd or 3rd degree atrioventricular block; * Oxygen need at a rate greater than 3L/min; * Glycemic decompensation in the last 12 hours.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Decompensated heart failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Hospitalar Universitário de Santo António - ULS Santo António
Porto, Porto District, 4099-001, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The impact of video-based cardiac rehabilitation education in patients with cardiovascular implantable electronic Devices(CIEDs)- a randomized controlled trial
- Effect of the use of dapagliflozin in diuresis, natriuresis and in ultrafiltration and peritoneal elimination of sodium, in patients with refractory heart failure
- Can a 10-Week coaching program ease the toll on heart failure caregivers?
- Can a 10-Second chest scan reveal hidden heart clues?
- Can AI help nurses guide At-Risk seniors to better care and lower costs?
- A Body-Scan test may reveal hidden fluid buildup, guiding early diuretic use